# Cancer Clinical Trial Eligibility Criteria: Laboratory Values: Draft Guidance for Industry, IRBs, and Clinical Investigators - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/cancer-clinical-trial-eligibility-criteria-laboratory-values-draft-guidance-for-industry-irbs-and-clinical-investigators/cf0069be-0465-448a-99af-11f54aa88dfd

> FDA guidance document: Cancer Clinical Trial Eligibility Criteria: Laboratory Values: Draft Guidance for Industry, IRBs, and Clinical Investigators. Issue date: April 25, 2024. Get complete insights and analysis.

---

## Details

- Title: Cancer Clinical Trial Eligibility Criteria: Laboratory Values: Draft Guidance for Industry, IRBs, and Clinical Investigators
- Communication Type: Guidance Document
- Product Type: other
- Office Name: Office of the Commissioner
- Office URL: /offices/office-of-the-commissioner/79483979-9582-427f-ac3d-46c715811424
- Issue Date: 2024-04-25
- Comment Close Date: 2024-06-25
- Last Changed: 2024-04-25
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2024-D-1402">FDA-2024-D-1402</a>

## Related Documents

- [Cancer Clinical Trial Eligibility Criteria: Performance Status: Draft Guidance for Industry, IRBs, and Clinical Investigators](https://www.globalkeysolutions.net/guidances/guidance-document/cancer-clinical-trial-eligibility-criteria-performance-status-draft-guidance-for-industry-irbs-and-clinical-investigators/cf636800-9d9c-44a9-a346-a5cd9d380d56)
- [Cancer Clinical Trial Eligibility Criteria: Washout Periods and Concomitant Medications: Draft Guidance for Industry, IRBs, and Clinical Investigators](https://www.globalkeysolutions.net/guidances/guidance-document/cancer-clinical-trial-eligibility-criteria-washout-periods-and-concomitant-medications-draft-guidance-for-industry-irbs-and-clinical-investigators/ab8bf32b-a854-471f-87a8-ba2ee2a5a8b0)
- [Clinical Trial Considerations to Support Accelerated Approval of Oncology Therapeutics](https://www.globalkeysolutions.net/guidances/guidance-document/clinical-trial-considerations-to-support-accelerated-approval-of-oncology-therapeutics/adf9cb72-5955-4d5f-8f26-4e226281ace9)